If you are an IMT2/IM3 interested in an Academic Clinical Fellowships in Infectious Diseases OR a post-PhD ID Registrar interested in an Academic Clinical Lectureships then sign-up for our pan-London open evening 7th October forms.gle/CTBtU6DbqzvMvD…

If you are a HCW including nurses, pharmacist, biomedical scientist, or any other type of allied health professional interested in a Global Health PhD London School of Hygiene & Tropical Medicine - I'd be happy to speak to you and provide guidance on the process. Do get in touch

Kicking off #IUSTI2024 - the message from Lancet 20 years ago 'Avoiding HIV and Dying of Syphilis' remains sadly relevant with inadequate progress globally. thelancet.com/journals/lance…

Remco Peters World Health Organization (WHO) highlights that the burden of curable STIs remains enormous and we have had almost no progress over ~2 decades. Contrast to HIV where we have seen transformative treatments and care delivery emerge over the same time period.

We haven't moved on much in terms of tackling #stigma associated with #STIs & the barriers this creates to improving STI control. This poster from 1937 highlighted by Nicola Low #EveryDayCounts #StillFBPE wouldn't look out of place today #IUSTI2024

We are currently ~8 fold above the WHO target for Elimination of Mother to Child Transmission of Syphilis Phoebe Williams & there are issues at every stage of the care cascade #IUSTI2024

WANTAIM study Kirby Institute, UNSW & PNG Institute of Medical Research in The Lancet Global Health thelancet.com/journals/langl… Landmark in evaluating impact STI testing & Rx on pregnancy outcomes. Complex results: NO overall benefit but was in those with GC ?Anti-malarial Rx impacted chlamydia in both arms & therefore findings?

Women with HIV & syphilis had a much higher rate of MTCT HIV in Brazilian data #IUSTI2024 Most of the risk is driven by differences in population - syphilis an indicator for social vulnerability.

Nice presentation from South Africa on association between CT/GC & reproductive outcomes #IUSTI2024 Nicola Low #EveryDayCounts #StillFBPE. Limitations given quality routine data in context syndromic management but broadly concordant with recent Netherlands data The Lancet Reg Health-Europe sciencedirect.com/science/articl…

#Mpox at #IUSTI2024 Dimie Ogoina gives the essential overview of where we are now… And how his early warnings from Nigeria in 2017 about transmission through sexual contact of monkeypox virus were ignored - now known to be clade IIb

Overview from Shivani Pasricha of using CRISPR based technologies for STI detection. Nice recent output from their group bioRxiv biorxiv.org/content/10.110… presents their end-to-end bio-informatics pipeline for designing guide RNAs & primers #IUSTI2024

Lovely talk from Eloise Williams on why we might want to revisit the frequency of screening for asymptomatic chlamydia & gonorrhoea. This is well summarised in a commentary The Lancet Infectious Diseases sciencedirect.com/science/articl…

Wrapping up at #IUSTI2024 International Union against STIs - huge thanks to Eric Chow for organising a fabulous meeting. See you all at #ISSTDR2025 in Montreal